tweenvest

BioGaia AB (publ) (OM: BIOG B)

Health Care · Biotechnology · SE

Skr125.80

+0.16% today · +25.2% 1Y

Public summary
A free snapshot of BioGaia AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

BioGaia AB (publ) (OM: BIOG B) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.25B.

Over the last twelve months the share price has gained 25.2%, trading between 96.20 and 136.30.

Tweenvest scores BioGaia AB (publ) across four factors: quality 90/100, value 36/100, growth 52/100, dividend 73/100. Its strongest factor is quality.

BIOG B price history

Nov 21, 2025 · 101.30Weekly closes 97.75 – 130.90Nov 19, 2026 · 125.80

Key figures

Market cap
$1.25B
Revenue (TTM)
$165.73M
P/E
32.51
EPS
3.87
Dividend yield
3.19%
Beta (5Y)
0.23
52-week high
Skr136.30
52-week low
Skr96.20
Avg volume (3M)
—
Shares outstanding
101.16M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403$1.26BCN¥8.99-0.66%
Metis TechBio Co., Ltd.SEHK: 7666$1.26BHK$8.36-19.69%
Idorsia LtdSWX: IDIA$1.26BCHF3.91-1.06%
Hualan Biological Vaccine Inc.SZSE: 301207$1.25BCN¥14.05-1.75%
Silence Therapeutics plcNasdaqGM: SLN$1.23B$19.83+0.15%
Taysha Gene Therapies, Inc.NasdaqGS: TSHA$1.23B$3.77-5.51%
Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739$1.23BCN¥19.94-0.35%
COMPASS Pathways plcNasdaqGS: CMPS$1.23B$8.65+6.53%

Browse every Biotechnology company →